ftInvstr
KILITCH · Healthcare ₹201.05 +5.21% Mkt Cap ₹704 Cr

KILITCH

Healthcare Drug Manufacturers - Specialty & Generic
₹201.05
+5.21% today · 30d -17.69%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for KILITCH. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹45 Cr
+4.03% YoY
NET PROFIT
₹2 Cr
-13.04% YoY
OPM
12.21%
-0.53pp YoY
EPS
₹0.83
PE 22.46
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-10.7% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
KILITCH22.4614.0
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
64
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 75
Valuation REASONABLE 60
Growth STEADY 65
Profitability DECENT 58
Technicals WEAK 45
Risk LOW 80
Key Stats
TTM PE
22.46
P/B
2.47
52W HIGH
₹267.9
OFF HIGH
-24.95%
DIV YIELD
0.0%
MKT CAP
₹704 Cr
◉ Active Signals
MACDBearish-2.0817
RSI(14)Neutral45.8
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold KILITCH and at what entry.

Sign up freeSign in